Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Hashem, Hasan; Dimitrova, Dimana; Meyts, Isabelle

Hashem, Hasan; Dimitrova, Dimana; Meyts, Isabelle.

Afiliação

Hashem H; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Bone Marrow Transplant Unit, King Hussein Cancer Center (KHCC), Amman, Jordan.
Dimitrova D; Experimental Transplantation and Immunotherapy Branch, National Cancer Institute of the National Institutes of Health, Bethesda, MD, United States.
Meyts I; Department of Pediatrics, Microbiology, Immunology, and Transplantation, The European Reference Network Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network (ERN RITA) Core Center, University Hospitals Leuven, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.

Front Immunol ; 13: 932385, 2022.

Article em En | MEDLINE | ID: mdl-35911698

Assuntos

Adenosina Desaminase; Transplante de Células-Tronco Hematopoéticas; Síndromes de Imunodeficiência; Adenosina Desaminase/genética; Transplante de Células-Tronco Hematopoéticas/métodos; Humanos; Síndromes de Imunodeficiência/terapia; Peptídeos e Proteínas de Sinalização Intercelular/genética; Mutação; Acidente Vascular Cerebral Lacunar; Vasculite/etiologia

Palavras-chave

DADA2; HCT; bone marrow failure; deficiency of adenosine deaminase 2; hematopoietic cell transplantation; immune dysregulation; immunodeficiency; inborn error of immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina Desaminase / Transplante de Células-Tronco Hematopoéticas / Síndromes de Imunodeficiência Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google